Relegard
Product Images NDC 51674-0130

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Relegard (NDC 51674-0130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blansett Pharmacal Co, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Relagard Proof 7.25.02_page_1 (Relagard Proof 7.25.02 Page 1)

Relagard Proof 7.25.02_page_1 (Relagard Proof 7.25.02 Page 1)
This is a patient information sheet focused on a medication called "elagard", which is a vaginal gel with an applicator. The information advises patients not to use the medication orally or in the eyes. It also lists the various chemical compounds that make up the therapeutic ingredients in the medication. The box contains one applicator, and there is prescription information included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.